This week, we are going to continue down the road of autoimmune peripheral nerve conditions to discuss two that we have touched on in the past—Guillain-Barré Syndrome and CIDP (chronic inflammatory ...

The FDA on March 16 approved CSL Behring’s drug Hizentra to treat chronic inflammatory demyelinating polyneuropathy. Hizentra is the first subcutaneous immunoglobulin approved to treat CIDP, a rare ...

Chicago runner Lynn Rogers knows the brain and nervous system in detail. After all, she earned her Ph.D. in biomedical engineering. Every day in her research, she uses non-invasive brain stimulation ...

Sponsored Content by GBS-CIDP Foundation Intl. Rare disorders are often hard to diagnose, treat and cure. That is why education and research are so important. Such is the case for Guillain Barre or ...

Dear Dr. Roach: My daughter has had symptoms of Guillain-Barre syndrome since her 20s. She is now 64 and has been doing fairly well. She is ambulatory and curious about her future. — P.B. Answer: ...

Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground. But when he failed to get up and told us that his legs hurt, my husband and I grew ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) may be a rare disease, but it is one of the most common forms of neuropathy and the most common form of chronic autoimmune neuropathy. Roughly ...

Chicago runner Lynn Rogers knows the brain and nervous system in detail. After all, she earned her Ph.D. in biomedical engineering. Every day in her research, she uses non-invasive brain stimulation ...

FRESNO, Calif. (KFSN) -- Turning pain into action. It's been eight years since Rob Vasquez was diagnosed with Guillain-Barré Syndrome. "It's been a long journey," said Cheryl Vasquez, Rob's wife. "For ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Although Guillain-Barré syndrome (GBS) may rarely follow a recent infection with SARS-CoV-2, a ...